Huons Co., Ltd. (KOSDAQ:243070)
21,400
-800 (-3.60%)
Aug 31, 2026, 3:30 PM KST
Huons Revenue
Huons had revenue of 141.87B KRW in the quarter ending March 31, 2026, a decrease of -2.72%. This brings the company's revenue in the last twelve months to 616.80B, up 4.84% year-over-year. In the year 2025, Huons had annual revenue of 620.77B with 5.17% growth.
Revenue (ttm)
616.80B
Revenue Growth
+4.84%
P/S Ratio
0.41
Revenue / Employee
666.40M
Employees
912
Market Cap
249.35B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 620.77B | 30.54B | 5.17% |
| Dec 31, 2024 | 590.23B | 38.22B | 6.92% |
| Dec 31, 2023 | 552.01B | 59.62B | 12.11% |
| Dec 31, 2022 | 492.39B | 55.48B | 12.70% |
| Dec 31, 2021 | 436.91B | 30.23B | 7.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| JW Holdings | 1.01T |
| Chong Kun Dang Holdings | 961.64B |
| Suheung | 765.90B |
| Samjin Pharmaceuticals | 274.03B |
| Whan In Pharm | 273.47B |
| Korea United Pharm | 161.44B |
| Yungjin Pharm. | 158.79B |
| REYON Pharmaceutical | 143.37B |